Stocks Hitting 52-Week Highs

Esperion Therapeutics

shares reached a new 52-week high of $27.905 after the company announced positive top-line Phase 2b results for ETC-1002. Sagent Pharmaceuticals

shares touched a new 52-week high of $32.12 after the company announced the acquisition of Omega Laboratories. Reis

shares touched a new 52-week high of $24.11. Reis shares have jumped 45.04% over the past 52 weeks, while the S&P 500 index has gained 14.89% in the same period. Handy & Harman

shares reached a new 52-week high of $28.55. Handy & Harman's trailing-twelve-month ROE is 27.52%.